ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,029Medicare Part D Prescriptions Filled, Including Refills

Rank: 159 out of 2604

$594K Total Retail Price of All Prescriptions

Rank: 124 out of 2604

388 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 388 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

25% of this provider’s 388 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 7,839 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 505 386 S3 1 1
SIMVASTATIN 360 310 2 2
LEVOTHYROXINE SODIUM 340 321 3 4
OMEPRAZOLE 262 224 4 5
AMLODIPINE BESYLATE 241 228 5 6
FUROSEMIDE 216 208 6 8
METOPROLOL TARTRATE 212 199 7 9
LISINOPRIL 193 170 8 3
METFORMIN HCL 173 147 9 7
PRAVASTATIN SODIUM 143 131 10 14
LANTUS 143 126 10 40
LISINOPRIL-HYDROCHLOROTHIAZIDE 134 113 12 22
POTASSIUM CHLORIDE 118 107 13 16
BUMETANIDE 117 106 14 70
GABAPENTIN 116 111 15 12
CITALOPRAM HBR 112 98 16 18
TRAMADOL HCL 107 100 17 15
ATORVASTATIN CALCIUM 103 81 18 19
CYMBALTA 89 70 19 44
MIRTAZAPINE 82 79 20 52
JANTOVEN 82 74 20 118
CARVEDILOL 81 72 22 26
FENTANYL 77 65 S2 23 48
CYCLOBENZAPRINE HCL 76 44 R 24 43
ACETAMINOPHEN-CODEINE 76 75 S3 24 60
KLOR-CON M10 76 73 24 159
POLYETHYLENE GLYCOL 3350 71 69 27 42
DONEPEZIL HCL 70 70 28 28
ACTOS 67 53 29 116
WARFARIN SODIUM 67 53 29 13
CELEBREX 67 52 29 114
TAMSULOSIN HCL 67 66 29 30
SPIRONOLACTONE 65 63 33 78
CARBIDOPA-LEVODOPA 63 49 34 97
HUMALOG MIX 75-25 62 46 35 385
ZOLPIDEM TARTRATE 62 49 35 21
CRESTOR 61 48 37 47
NOVOLOG 61 58 37 89
TRIAMCINOLONE ACETONIDE 60 44 39 125
ISOSORBIDE MONONITRATE ER 60 60 39 38
METHADONE HCL 59 30 S2 41 67
ADVAIR DISKUS 59 58 41 41
NEXIUM 59 59 41 53
FAMOTIDINE 59 55 41 68
IBUPROFEN 58 42 45 32
KLOR-CON M20 58 52 45 86
BISOPROLOL-HYDROCHLOROTHIAZIDE 57 50 47 133
DIGOXIN 56 49 48 71
CLOPIDOGREL 55 52 49 39
SERTRALINE HCL 55 52 49 23
ATENOLOL 51 49 51 11
ESCITALOPRAM OXALATE 50 40 52 73
METOPROLOL SUCCINATE 50 42 52 17
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 4, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.